RxDoctor Payments Data

Benjamin Goldstein

Hospice and Palliative Medicine · Cumberland, MDNPI 1578978383

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,597 of the $2,011 with a category attached, or 79.4%. 16 manufacturers reported payments, led by Medtronic at 31.0% of the total. Reporting peaked in 2019 at $624 and has fallen 61.0% since, to $243 in 2025. Among hospice and palliative medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,011in general payments, 2019–2025

Across 36 payments — averaging $55.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$624
  • AstraZeneca$302
  • AbbVie$277
  • GSK$200
  • Grifols USA, LLC$161
  • E.r. Squibb & Sons, L.L.C.$120
  • plus $326 from 10 others

What the payments were for

  • Travel & lodging$41421%
  • Food & beverage$1,59779%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,011 in reported general payments places this provider in the 95th percentile of 35 hospice and palliative medicine providers in Maryland.

See all hospice and palliative medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$137,435
Medicare patients
407
Services billed
1,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate40$27,036
OxycontinOxycodone Hcl18$12,480
Oxycodone Hcl130$3,058
Fentanyl15$1,357
Morphine Sulfate36$987
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$751
Gabapentin60$622
Morphine Sulfate ErMorphine Sulfate29$616
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$538
Duloxetine Hcl30$425
Pregabalin47$382
Tramadol Hcl27$317
Ondansetron OdtOndansetron16$256
Ondansetron Hcl16$226
Alprazolam19$161

Paid to pharmacies, not to this prescriber.

Other hospice and palliative medicine in Cumberland

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →